Neurophysiology and MRI in late-infantile metachromatic leukodystrophy

Pediatric Neurology

Volumn 21, Issue 5, 1999, Pages 843-846

  Zafeiriou, Dimitrios I ^a   Kontopoulos, Eleftherios E ^a   Michelakakis, Helen M ^b   Anastasiou, Athanasia L ^c   Gombakis, Nikos P ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Institute of Child Health   (Greece)

^c Ippokration Hospital Thessaloniki   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROSIDE SULFATASE; VIGABATRIN;

ARTICLE; BRAIN ATROPHY; CASE REPORT; CHILD; ELECTROENCEPHALOGRAM; ENZYME DEFICIENCY; EVOKED RESPONSE; FEMALE; GAIT DISORDER; HUMAN; LEUKODYSTROPHY; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUADRIPLEGIA; SEIZURE; WHITE MATTER;

BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; EVOKED POTENTIALS; FEMALE; HUMANS; LEUKODYSTROPHY, METACHROMATIC; MAGNETIC RESONANCE IMAGING; NEURAL CONDUCTION;

EID: 0032698403     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(99)00093-4     Document Type: Article

References (15)

1. Kolodny E.H., Fluharty A.L. Metachromatic leukodystrophy and multiple sulfatase deficiency Sulfatide lipidosis . Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic basis of inherited disease. 7th ed. 1995;2693-2739 McGraw-Hill, New York.
2. Takakura H., Nakamo C., Kasagi S., Takashima S., Takeshita K. Multimodality evoked potentials in progression of metachromatic leukodystrophy. Brain Dev. 7:1985;424-430.
3. Barkovich A.J. Pediatric neuroimaging. 1996;87-91 Lippincott-Raven, Philadelphia.
4. Kim T.S., Kim I.O., Kim W.S., Choi Y.S., Lee J.Y., Kim O.W., et al. MR of childhood metachromatic leukodystrophy. Am J Neuroradiol. 18:1997;733-738.
5. Demaerel P., Faubert C., Wilms G., Casaer P., Piepgras U., Baert A.L. MR findings in leukodystrophy. Neuroradiology. 33:1991;368-371.
6. Malm G., Ringdin O., Winiarski J., et al. Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant. 17:1996;1003-1008.
7. Stillman A.E., Krivit W., Shapiro E., Lockman L., Latchaw R.E. Serial MR after bone marrow transplantation in two patients with metachromatic leukodystrophy. Am J Neuroradiol. 15:1994;1929-1932.
8. Martinez A.C., Ferrer M.T., Fueyo E., Galdos L. Peripheral neuropathy detected on an electrophysiological study as the manifestation of MLD in infancy. J Neurol Neurosurg Psychiatry. 38:1975;169-174.
9. De Silva K.L., Pearce J. Neuropathy of metachromatic leukodystrophy. J Neurol Neurosurg Psychiatry. 36:1973;30-33.
10. Krivit W., Lipton M.E., Lockman L.A., et al. Prevention of deterioration in metachromatic leukodystrophy by bone marrow transplantation. Am J Med Sci. 294:1987;80-85.
11. Dhuna A., Toro C., Torres F., Kennedy W.R., Krivit W. Longitudinal neurophysiological studies in a patient with metachromatic leukodystrophy following bone marrow transplantation. Arch Neurol. 49:1992;1088-1092.
12. Nevo Y., Pestronk A., Lopate G., Carroll S.L. Neuropathy of metachromatic leukodystrophy Improvement with immunomodulation . Pediatr Neurol. 15:1996;237-239.
13. Balslev T., Cortez M.A., Blaser S.I., Haslam R.H.A. Recurrent seizures in metachromatic leukodystrophy. Pediatr Neurol. 17:1997;150-154.
14. Kurlemann G., Palm D.G. Vigabatrin in metachromatic leukodystrophy Positive influence on spasticity . Dev Med Child Neurol. 33:1991;182.
15. Mackenzie R., Klistorner A. Severe persisting visual defect constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ. 316:1998;233.